Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

Overcoming distribution hurdles to meet demand, cold chain solutions and strategies, and streamlining the supply chain to mitigate rising costs. Unique capabilities needed to overcome obstacles for ...

Risk assessment approaches, employing appropriate control strategies, and robust analytical methods can ensure high-quality and safe medicines. Tips to avoid IP contamination in manufacturing ...

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Prasinezumab continues to be well tolerated and no new safety signals were observed.

The acquisition is expected to be completed in the coming days.

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of ...

A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...

With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and ...

In anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, BioVaxys ...

Partnership leverages PHICS technology to bring together a kinase and target of interest to modulate protein function.

Hansoh Pharma will receive $112 million upfront and is eligible to receive up to $1.9 billion in milestone payments.